Description
N/A
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.0
Trade Value (12mth)
N/A
1 week
-4.76%
1 month
-4.76%
YTD
-86.21%
1 year
-84%
All time high
N/A
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
N/A
Short Sell (% of issue)
N/A
Date | Announcements |
---|---|
30 March 22 |
Investor Roadshow Presentation
×
Investor Roadshow Presentation |
30 January 23 |
Quarterly Activities Report and Appendix 4C
×
Quarterly Activities Report and Appendix 4C |
30 August 21 |
Annual Report to 30 June 2021
×
Annual Report to 30 June 2021 |
30 April 20 |
Nyrada Preclinical Program & Corporate Update Presentation
×
Nyrada Preclinical Program & Corporate Update Presentation |
29 September 22 |
Presentation to ShareCafe Hidden Gems Webinar
×
Presentation to ShareCafe Hidden Gems Webinar |
29 March 22 |
New Drug Offers Potential Oral Treatment for Concussion
×
New Drug Offers Potential Oral Treatment for Concussion |
29 June 22 |
Cholesterol-Lowering Program Update
×
Cholesterol-Lowering Program Update |
29 August 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
29 August 22 |
Preliminary Final Report
×
Preliminary Final Report |
29 August 22 |
Annual Report to June 30 2022
×
Annual Report to June 30 2022 |
29 August 22 |
Nyrada Reports Full Year FY2022 Results
×
Nyrada Reports Full Year FY2022 Results |
28 July 23 |
Quarterly Activities Report and Appendix 4C
×
Quarterly Activities Report and Appendix 4C |
28 August 23 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
28 August 23 |
Preliminary Final Report
×
Preliminary Final Report |
28 August 23 |
Annual Report for year ended 30 June 2023
×
Annual Report for year ended 30 June 2023 |
28 August 23 |
Full Year Results FY2023
×
Full Year Results FY2023 |
27 October 22 |
CEO Remuneration Update
×
CEO Remuneration Update |
27 February 20 |
Nyrada Inc. Corporate Presentation February 2020
×
Nyrada Inc. Corporate Presentation February 2020 |
26 October 22 |
Quarterly Activities Report and Appendix 4C
×
Quarterly Activities Report and Appendix 4C |
26 May 23 |
Cholesterol-Lowering Program Preclinical Studies Completed
×
Cholesterol-Lowering Program Preclinical Studies Completed |
26 June 23 |
Cholesterol-Lowering Program Update
×
Cholesterol-Lowering Program Update |
26 July 22 |
Quarterly Activities Report and Appendix 4C
×
Quarterly Activities Report and Appendix 4C |
26 April 23 |
Quarterly Activities Report and Appendix 4C
×
Quarterly Activities Report and Appendix 4C |
25 February 22 |
Appendix 4D and Half Year Report to 31 December 2021
×
Appendix 4D and Half Year Report to 31 December 2021 |
25 February 22 |
Nyrada Half Year Results FY2022
×
Nyrada Half Year Results FY2022 |
24 June 20 |
Corporate Presentation for the Reach Markets Virtual Event
×
Corporate Presentation for the Reach Markets Virtual Event |
24 February 23 |
Appendix 4D and Half Year Report to 31 December 2022
×
Appendix 4D and Half Year Report to 31 December 2022 |
24 February 23 |
Nyrada Half Year Results FY2023
×
Nyrada Half Year Results FY2023 |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.